| Literature DB >> 28604785 |
Justyna Horodyska1,2, Ruth M Hamill1, Patrick F Varley3, Henry Reyer2, Klaus Wimmers2,4.
Abstract
Feed conversion efficiency is a measure of how well an animal converts feed into live weight and it is typically expressed as feed conversion ratio (FCR). FCR and related traits like growth rate (e.g. days to 110 kg-D110) are of high interest for animal breeders, farmers and society due to implications on animal performance, feeding costs and environmental sustainability. The objective of this study was to identify genomic regions associated with FCR and D110 in pigs. A total of 952 terminal line boars, showing an individual variation in FCR, were genotyped using 60K SNP-Chips. Markers were tested for associations with estimated breeding values (EBV) for FCR and D110. For FCR, the largest number of associated SNPs was located on chromosomes 4 (30 SNPs), 1 (25 SNPs), X (15 SNPs) and 6 (12 SNPs). The most prominent genomic regions for D110 were identified on chromosomes 15 (10 SNPs), 1 and 4 (both 9 SNPs). The most significantly associated SNPs for FCR and D110 mapped 129.8 Kb from METTL11B (chromosome 4) and 32Kb from MBD5 (chromosome 15), respectively. A list of positional genes, closest to significantly associated SNPs, was used to identify enriched pathways and biological functions related to the QTL for both traits. A number of candidate genes were significantly overrepresented in pathways of immune cell trafficking, lymphoid tissue structure, organ morphology, endocrine system function, lipid metabolism, and energy production. After resequencing the coding region of selected positional and functional candidate genes, six SNPs were genotyped in a subset of boars. SNPs in PRKDC, SELL, NR2E1 and AKRIC3 showed significant associations with EBVs for FCR/D110. The study revealed a number of chromosomal regions and candidate genes affecting FCR/D110 and pointed to corresponding biological pathways related to lipid metabolism, olfactory reception, and also immunological status.Entities:
Mesh:
Year: 2017 PMID: 28604785 PMCID: PMC5467825 DOI: 10.1371/journal.pone.0173482
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Forward and reverse primers for PCR amplification of the twelve selected positional candidate genes located within 1Mb of the genome-wide significant markers for EBVs FCR and D110.
| Gene | Ensembl reference | Size (bp) | Forward | Reverse |
|---|---|---|---|---|
| 713 | ||||
| 706 | ||||
| 697 | ||||
| 735 | ||||
| 706 | ||||
| 350 | ||||
| 718 | ||||
| 567 | ||||
| 792 | ||||
| 702 | ||||
| 773 | ||||
| 696 |
Fig 1Manhattan plot of the genome-wide association analysis of EBV FCR.
The red and blue lines indicate the suggestive (-log10[p-value] ≥ 4.7) and the Bonferroni-adjusted genome-wide significance threshold (-log10[p-value] ≥ 6), respectively.
Genes located closest to the genome-wide significant SNPs.
| EBV | SNP | Neglog10 (p-value) | SSC | Position (bp) | Region | Nearest gene | Gene position (bp) |
|---|---|---|---|---|---|---|---|
| FCR | H3GA0002102 | 6.32 | 1 | 84,686,166 | Intronic | ||
| FCR | MARC0000845 | 6.26 | 4 | 86,747,415 | Intergenic | 86,796,081–86,804,148 | |
| FCR | ALGA0026204 | 6.47 | 4 | 87,021,547 | Intergenic | 87,134,012–87,185,073 | |
| FCR | H3GA0013204 | 7.96 | 4 | 88,311,790 | Intergenic | 88,441,595–88,460,670 | |
| FCR | ALGA0026230 | 6.84 | 4 | 89,104,182 | Intronic | 89,027,936–89,109,573 | |
| FCR | ALGA0026233 | 6.91 | 4 | 89,118,147 | Intergenic | 89,027,936–89,109,573 | |
| FCR | ASGA0028724 | 6.44 | 6 | 78,297,229 | Intergenic | 78,358,088–78,326,491 | |
| FCR | ALGA0035847 | 6.43 | 6 | 80,577,487 | Intergenic | 80,106,273–80,024,322 | |
| FCR | MARC0015113 | 7.40 | 15 | 146,404,317 | Intronic | 146,381,891–146,596,424 | |
| FCR | ALGA0119312 | 6.27 | 15 | 149,350,761 | Intergenic | 149,122,784–149,123,362 | |
| D110 | ALGA0060013 | 6.32 | 10 | 72,375,760 | Intergenic | 72,091,036–72,106,952 | |
| D110 | H3GA0030777 | 6.92 | 10 | 72,766,001 | Intergenic | 72,992,245–73,001,823 | |
| D110 | MARC0036947 | 6.92 | 15 | 2,640,639 | Intergenic | 2,443,675–2,456,793 | |
| D110 | ALGA0115976 | 6.89 | 15 | 2,798,633 | Intronic | 2,730,359–2,901,565 | |
| D110 | ALGA0113899 | 6.78 | 15 | 2,835,746 | Intronic | 2,730,359–2,901,565 | |
| D110 | MARC0072361 | 7.75 | 15 | 2,843,921 | Intronic | 2,730,359–2,901,565 | |
| D110 | ALGA0083417 | 8.15 | 15 | 3,322,649 | Intergenic | 3,354,689–3,361,520 |
$Estimated breeding value;
*Sscrofa 10.2 assembly
Fig 2Manhattan plot of the genome-wide association analysis of EBV D110.
The red and blue lines indicate the suggestive (-log10[p-value] ≥ 4.7) and the Bonferroni-adjusted genome-wide significance threshold (-log10[p-value] ≥ 6), respectively.
Top molecular themes for the positional and functional candidate genes located within 1Mb of the genome-wide significant markers for EBV of FCR and D110.
| EBV | Category | B-H p-value | Genes |
|---|---|---|---|
| FCR | Hematological System Development and Function | 8.53E-05-9.68E-02 | |
| FCR | Immune Cell Trafficking | 8.53E-05-9E-02 | |
| FCR | Lymphoid Tissue Structure and Development | 2.89E-03-9E-02 | |
| FCR | Organ Morphology | 2.89E-03-9.68E-02 | |
| FCR | Organismal Development | 2.89E-03-9.14E-02 | |
| D110 | Endocrine System Development and Function | 4.7E-06-8.62E-02 | |
| D110 | Small Molecule Biochemistry | 4.7E-06-6.21E-02 | |
| D110 | Energy Production | 3.51E-05-2.45E-02 | |
| D110 | Lipid Metabolism | 6.06E-05-5.44E-02 | |
| D110 | Drug Metabolism | 3.68E-04-3.01E-02 |
*Range of B-H multiple testing correction p-values of enriched biological functions within the category; candidate genes selected for downstream validation are highlighted in bold
Top canonical pathways for the positional and functional candidate genes located within 1Mb of the genome-wide significant markers for EBV of FCR and D110.
| EBV | Ingenuity Canonical Pathways | P-value | Genes |
|---|---|---|---|
| FCR | Cell Cycle Control of Chromosomal Replication | 4.66E-03 | |
| FCR | Estrogen Receptor Signaling | 1.27E-02 | |
| FCR | PXR/RXR Activation | 2.59E-02 | |
| FCR | Granulocyte Adhesion and Diapedesis | 2.62E-02 | |
| FCR | Sphingomyelin Metabolism | 2.96E-02 | |
| D110 | Bile Acid Biosynthesis, Neutral Pathway | 5.57E-08 | |
| D110 | TR/RXR Activation | 1.87E-05 | |
| D110 | Androgen Biosynthesis | 3.32E-05 | |
| D110 | Methylglyoxal Degradation III | 4.38E-05 | |
| D110 | Retinoate Biosynthesis I | 1.91E-04 |
Candidate genes selected for downstream validation are highlighted in bold
Observed and expected heterozygosity of the SNPs selected for validation.
| Gene | SNP | Location (SSC 10.2) | Alleles | Variant | MAF | Observed heterozygosity | Expected heterozygosity | HWE |
|---|---|---|---|---|---|---|---|---|
| rs332368013 | 15:3,359,994 | A/G | missense | 0.300 | 0.471 | 0.420 | 0.014 | |
| rs340456509 | 1:83,552,036 | G/T | intron | 0.211 | 0.359 | 0.334 | 0.155 | |
| rs80900450 | 4:87,256,301 | C/T | missense | 0.268 | 0.370 | 0.392 | 0.282 | |
| rs319738340 | 4:88,935,116 | C/T | splice region | 0.166 | 0.276 | 0.276 | 1 | |
| rs81508945 | 10:72,102,793 | G/C | missense | 0.120 | 0.213 | 0.212 | 1 | |
| NOVEL | 6:79,658,669 | C/A | downstream | 0.022 | 0.044 | 0.043 | 1 |
£p-value for test for departure from Hardy-Weinberg Equilibrium (HWE);
*Significant departure from HWE (p<0.05)
Association of the five SNPs, located in selected functional genes mapped within 1Mb of the genome-wide significant markers, with breeding values for FCR and D110.
Lower breeding values indicate higher feed efficiency.
| SNP (gene) | Trait | P-value | Least squares means of EBVs per genotype | Additive effect | Dominant effect | ||||
|---|---|---|---|---|---|---|---|---|---|
| rs80900450 | C/C n = 36 | C/T n = 161 | T/T n = 238 | P-value | a | P-value | d | ||
| EBV D110 | 0.085 | -8.771 ±5.80 | -8.416 ±5.78 | -9.214 ±5.78 | |||||
| EBV FCR | -0.036 ±0.15 | -0.057 ±0.15 | -0.084 ±0.15 | 0.0377 (5%) | 0.838 | 0.0026 | |||
| rs319738340 | C/C n = 303 | C/T n = 120 | T/T n = 12 | ||||||
| EBV D110 | 0.366 | -8.899 ±5.78 | -8.389 ±5.78 | -9.142 ±5.86 | |||||
| EBV FCR | -0.073 ±0.15 | -0.049 ±0.15 | -0.047 ±0.15 | 0.852 | -0.0019 | 0.800 | 0.0048 | ||
| rs340456509 | G/G n = 265 | T/G n = 156 | T/T n = 14 | ||||||
| EBV D110 | -9.224 ±5.78 | -8.327 ±5.78 | -7.631 ±5.84 | -0.4849 (16%) | -0.2665 (1%) | ||||
| EBV FCR | -0.085 ±0.15 | -0.047 ±0.15 | -0.021 ±0.15 | -0.0230 (1%) | 0.559 | -0.0101 | |||
| rs81508945 | C/C n = 6 | C/G n = 93 | G/G n = 337 | ||||||
| EBV D110 | 0.195 | -6.632 ±5.92 | -8.561 ±5.79 | -8.953 ±5.78 | |||||
| EBV FCR | 0.468 | -0.043 ±0.15 | -0.058 ±0.15 | -0.069 ±0.15 | |||||
Significant associations are in bold;
1Additive (a) and dominant (d) effect of an allelic substitution on a phenotype;
2 Phenotypic variance in percentage explained by SNP; Where delta was not significant, the alpha was reported from the first regression model.